As DR ISO Malaysia, we support local and overseas manufacturers of aesthetic medical devices who want to access the Malaysian market with full regulatory compliance and strong quality credentials.
With the Medical Device (Designated Medical Device) Order under the Medical Device Act 2012 (Act 737), key aesthetic technologies such as medical lasers, High-Intensity Focused Ultrasound (HIFU) and liposuction devices are now clearly within Malaysia’s medical device regulatory framework.
This complete guide covers everything manufacturers need: how aesthetic devices are classified and designated, how to register them with the Medical Device Authority (MDA), how to prepare and use the Common Submission Dossier Template (CSDT), how ISO 13485 fits with Malaysian requirements, and how to integrate Malaysia into a broader ASEAN strategy.
For a full picture of the value chain, you may also wish to read our Complete Guide to Aesthetic Medical Device Distribution Compliance in Malaysia and Complete Guide to Aesthetic Medical Device Compliance for Clinics in Malaysia, which explain how your partners and customers must operate.
1. Aesthetic Devices as Designated Medical Devices
The Medical Device (Designated Medical Device) Order specifies that certain aesthetic technologies—such as Alexandrite, diode, Erbium YAG, Fractional CO2, Nd:YAG, pulse-dye and ruby lasers, along with HIFU systems and liposuction devices—are designated medical devices under Malaysian law.
Each entry in the Schedule defines typical uses, including hair removal, skin rejuvenation, pigment and vascular lesion treatment, actinic keratosis treatment, non-invasive lifting and local fat removal.
For manufacturers, this means that these aesthetic technologies can no longer be marketed into Malaysia as general beauty or cosmetic equipment.
They must be treated as medical devices under Act 737, with proper classification, technical documentation, conformity assessment and registration prior to supply or use.
2. Determining Classification and Intended Purpose
The first regulatory step for any manufacturer is to define the intended purpose of the device as used in Malaysia, and determine its risk class (Class A, B, C or D) using MDA’s classification rules.
For aesthetic lasers, HIFU systems and liposuction devices, the clinical uses and energy levels typically place them in higher risk classes, frequently Class C or D, though exact classification depends on detailed characteristics and intended use.
The intended purpose must be clearly described and consistently reflected in all labelling, instructions for use and promotional materials.
This description is central to class determination, grouping decisions and evaluation of whether the device falls within the Designated Medical Device Order and any ASEAN borderline product guidance.
3. Overview of Malaysia’s Medical Device Registration Framework
Malaysia’s registration framework generally follows these steps for non-Class A devices:
- Specify the device’s intended purpose, determine its class and decide on grouping (single device, family, system, or group).
- Compile technical documentation using the Common Submission Dossier Template (CSDT) as a summary of the full technical file.
- Conduct conformity assessment with a registered Conformity Assessment Body (CAB) to verify compliance with safety and performance requirements.
- Prepare and submit the CSDT and supporting documents via the MeDC@St online system, along with a declaration of conformity.
- Undergo evaluation by MDA, pay applicable fees, and obtain a registration certificate valid for a defined period.
For aesthetic devices, manufacturers should anticipate more detailed scrutiny of risk management, clinical evidence and labelling due to their higher risk profile and public interest.
It is also important to ensure that distributors and clinics understand and respect the intended purpose and conditions of use described in your registration, as explained in our Complete Guide to Aesthetic Medical Device Distribution Compliance in Malaysia and Complete Guide to Aesthetic Medical Device Compliance for Clinics in Malaysia.
4. CSDT: Structuring Your Technical Documentation
The Common Submission Dossier Template (CSDT) is the standard format MDA uses for registration applications.
It is a structured summary of your technical documentation and must be prepared carefully to demonstrate conformity with applicable requirements.
A typical CSDT for Class B, C or D devices includes:
- Executive summary and essential principles checklist.
- Detailed device description, variants and accessories.
- Summary of design verification and validation activities, including bench tests, software validation and performance studies.
- Summary of clinical evidence supporting safety and performance for the intended purposes, especially relevant for aesthetic outcomes and risk control.
- Labelling, instructions for use and promotional materials that will be used in Malaysia.
- Risk analysis and risk management documentation.
- Manufacturer information and, where applicable, authorised representative details.
For aesthetic lasers, HIFU systems and liposuction devices, manufacturers should ensure that validation and clinical evidence adequately address key risks such as burns, scarring, pigmentary changes, tissue damage and procedural complications.
5. Conformity Assessment and CAB Engagement
Most aesthetic devices fall under classes that require conformity assessment by a registered CAB before MDA will register the device.
Manufacturers need to appoint an appropriate CAB and provide the evidence of conformity summarised in the CSDT.
The CAB will review your documentation, quality management system, risk management and clinical evidence, and may request additional information or clarification.
Once satisfied, the CAB issues a conformity assessment report that supports your registration application with MDA.
6. ISO 13485 and Manufacturer Quality Management
ISO 13485 is the internationally recognised standard for medical device quality management systems, and it aligns closely with expectations for manufacturers under Malaysian regulation.
Implementing ISO 13485 helps ensure that design, development, production, installation and servicing are controlled systematically.
For aesthetic device manufacturers, ISO 13485 certification demonstrates that you have robust processes for risk management, design control, supplier management, complaint handling and post-market surveillance.
It also facilitates smoother CAB assessments and MDA evaluations, and supports recognition or reliance pathways where foreign approvals or certifications are considered.
7. Relationship Between ISO 13485, GDPMD and Distributor Obligations
While ISO 13485 focuses on manufacturers and full device lifecycle, Good Distribution Practice for Medical Devices (GDPMD) applies to authorised representatives, importers and distributors managing devices in the Malaysian supply chain.
Manufacturers must ensure that their partners implement GDPMD-compliant systems and hold valid establishment licences.
In practice, this means aligning your ISO 13485-certified quality system with your partners’ GDPMD systems, ensuring consistency in handling, storage, transport, traceability and complaint management.
Clear contracts and quality agreements should define responsibilities for incident reporting, field safety corrective actions and communication with MDA; our Complete Guide to Aesthetic Medical Device Distribution Compliance in Malaysia provides detailed expectations for these partners, and our GDPMD service helps them build compliant systems.
8. Singapore Reliance and Other Reference Market Pathways
Malaysia has developed guidance allowing certain reliance or verification pathways when devices are already approved in trusted reference markets such as Singapore or recognised regulatory authorities.
For aesthetic devices with approvals from the Health Sciences Authority (HSA) or other recognised bodies, these pathways may reduce duplication and speed up registration.
However, reliance pathways still require a full understanding of Malaysia’s classification, intended purpose and designation, and submission of CSDT documentation adapted to local requirements.
Manufacturers should not assume automatic acceptance; instead, they should treat foreign approvals as strong supporting evidence within the Malaysian framework.
9. ASEAN Strategy and Borderline Products
Malaysia is part of the ASEAN Medical Device Directive (AMDD) framework, which promotes harmonised definitions and borderline product lists across member countries.
For aesthetic technologies, ASEAN guidance helps determine whether products are medical devices, cosmetics, drugs or combination products based on intended purpose and mode of action.
Manufacturers targeting Malaysia and other ASEAN markets should review borderline guidance for products such as lasers, liposuction machines, soft tissue fillers and topical treatments.
This supports consistent classification, packaging and labelling strategies across the region and reduces regulatory friction when expanding beyond Malaysia.
10. Practical Roadmap for Aesthetic Device Manufacturers
To bring aesthetic medical devices into Malaysia in a compliant and efficient way, manufacturers can follow a structured roadmap:
- Define and document the device’s intended purpose for Malaysia, including all aesthetic indications and target user groups.
- Determine classification and grouping using MDA rules, taking into account the Designated Medical Device Order and ASEAN guidance.
- Implement or strengthen an ISO 13485 quality management system to support design, production and post-market control.
- Prepare a complete CSDT, summarising technical documentation, verification and validation, clinical evidence, risk management and labelling.
- Engage a registered CAB to conduct conformity assessment and issue a conformity report.
- Work with a GDPMD-compliant authorised representative or distributor in Malaysia who holds an establishment licence and understands local regulatory processes.
- Align device labelling, marketing and training materials with the responsibilities and governance expectations of clinics and aesthetic centres, as explained in our Complete Guide to Aesthetic Medical Device Compliance for Clinics in Malaysia.
- Submit the registration application via MeDC@St, respond to MDA queries, and integrate any conditions or post-market requirements into your quality system.
- Plan your ASEAN expansion by aligning classification, labelling and technical documentation with regional expectations and borderline guidance.
11. How DR ISO Malaysia Can Support Manufacturers
We work with aesthetic device manufacturers—both Malaysian and overseas—to design and execute complete registration and quality strategies for the Malaysian market.
Our support can cover ISO 13485 implementation, CSDT preparation, CAB engagement, reliance pathway assessment, and coordination with GDPMD-certified local partners.
We also help you map Malaysia’s requirements into your broader ASEAN and global regulatory strategy, so that investments in documentation and quality systems yield maximum value across multiple markets.
To discuss your aesthetic device registration plans, ISO 13485 needs or ASEAN expansion strategy, please contact us through our contact page, and consider sharing our Complete Guide to Aesthetic Medical Device Distribution Compliance in Malaysia and Complete Guide to Aesthetic Medical Device Compliance for Clinics in Malaysia with your Malaysian partners to align the full pathway from device design to patient treatment.